Platelet Transfusion Refractoriness
📧 Sign up to get email alerts when something new happens for Platelet Transfusion Refractoriness.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion
This clinical trial evaluates the relationship between C1q binding to HLA antibodies (measured in a solid-phase immunoassay) and the clinica…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness [Phase 1, Phase 2]
This document outlines a Phase 1/2 clinical trial of CM313(SC) Injection for platelet transfusion refractoriness. The study is currently rec…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: RN1201 Injection in the Treatment of Antibody-Mediated Diseases [Phase 1]
Phase 1 trial update for RN1201 Injection targeting antibody-mediated platelet disorders. The study includes refractory immune-mediated plat…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: The SOLID Platelet Study [Phase 2]
Phase 2 SOLID Platelet Study investigating therapies for platelet transfusion refractoriness and thrombocytopenia has been terminated with r…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia [Phase 1]
Phase 1 trial evaluating daratumumab to overcome platelet transfusion refractoriness in patients with aplastic anemia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL [Phase 1, Phase 2]
A Phase 1/2 trial evaluating sequential infusion of CD19 and BCMA CAR-T cells for improving platelet transfusion refractoriness in acute leu…